| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Cellebrite DI Ltd
Cellebrite DI Ltd
NASDAQ:CLBT
Cellebrite DI Ltd
Accounts Payable
Cellebrite DI Ltd
Accounts Payable Peer Comparison
WKME
SPNS
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cellebrite DI Ltd
NASDAQ:CLBT
|
Accounts Payable
$53.1m
|
CAGR 3-Years
124%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
R
|
Riskified Ltd
NYSE:RSKD
|
Accounts Payable
$2.6m
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Walkme Ltd
NASDAQ:WKME
|
Accounts Payable
$3.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sapiens International Corporation NV
NASDAQ:SPNS
|
Accounts Payable
$9.8m
|
CAGR 3-Years
17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
N
|
Nice Ltd
TASE:NICE
|
Accounts Payable
$66m
|
CAGR 3-Years
26%
|
CAGR 5-Years
17%
|
CAGR 10-Years
10%
|
|
H
|
Hilan Ltd
TASE:HLAN
|
Accounts Payable
₪833.4m
|
CAGR 3-Years
66%
|
CAGR 5-Years
14%
|
CAGR 10-Years
25%
|
See Also
What is Cellebrite DI Ltd's Accounts Payable?
Accounts Payable
53.1m
USD
Based on the financial report for Dec 31, 2023, Cellebrite DI Ltd's Accounts Payable amounts to 53.1m USD.
What is Cellebrite DI Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 3Y
124%
Over the last year, the Accounts Payable growth was 1 055%. The average annual Accounts Payable growth rates for Cellebrite DI Ltd have been 124% over the past three years .
You don't have any saved screeners yet
